Inactive Instrument

News Regenicin, Inc. Other OTC

Equities

RGIN

US75887Q1022

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-15	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-02-13	AQ
Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-13	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-01-13	AQ
Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-13	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-12	AQ
Regenicin, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-12	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-23	AQ
Regenicin, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-23	CI
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	22-03-25	AQ
REGENICIN, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	22-03-25	AQ
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-02-14	AQ
Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	22-02-14	CI
REGENICIN, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations	22-02-08	AQ
REGENICIN, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-01-13	AQ
Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	22-01-13	CI
REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-08-23	AQ
Regenicin, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	21-08-23	CI
REGENICIN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-05-17	AQ
Regenicin, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	21-05-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Regenicin, Inc. Other OTC

Equities

RGIN

US75887Q1022

Summary

Filters